Impact of TiO2 Surface Defects on the Mechanism of Acetaldehyde Decomposition under Irradiation of a Fluorescent Lamp

TiO2 was placed in heat-treatment at the temperature of 400–500 °C under flow of hydrogen gas in order to introduce some titania surface defects. It was observed that hole centers in TiO2 were created during its heat treatment up to 450 °C, whereas at 500 °C some Ti3+ electron surface defects appeared. The type of titania surface defects had a great impact on the mechanism of acetaldehyde decomposition under irradiation of artificial visible light. Formation of O•− defects improved both acetaldehyde decomposition and mineralization due to the increased oxidation of adsorbed acetaldehyde molecules by holes. Contrary to that, the presence of electron traps and oxygen vacancies in titania (Ti3+ centers) was detrimental for its photocatalytic properties towards acetaldehyde decomposition. It was proved that transformation of acetaldehyde on the TiO2 with Ti3+ defects proceeded through formation of butene complexes, similar as on rutile-type TiO2. Formed acetic acid, upon further oxidation of butene complexes, was strongly bound with the titania surface and showed high stability under photocatalytic process. Therefore, titania sample heat-treated with H2 at 500 °C showed much lower photocatalytic activity than that prepared at 450 °C. This study indicated the great impact of titania surface defects (hole traps) in the oxidation of acetaldehyde and opposed one in the case of defects in the form of Ti3+ and oxygen vacancies. Oxidation abilities of TiO2 seem to be important in the photocatalytic decomposition of volatile organic compounds (VOCs) such as acetaldehyde.This research was funded by the National Science Centre, Poland, grant nr 2020/39/B/ST8/01514

New Gd3+ and Mn2+-Co-Doped Scheelite-Type Ceramics—Their Structural, Optical and Magnetic Properties

New Gd3+- and Mn2+-co-doped calcium molybdato-tungstates with the chemical formula of Ca1−3x−yMny▯xGd2x(MoO4)1−3x(WO4)3x (labeled later as CaMnGdMoWO), where ▯ denotes vacant sites in the crystal lattice, 0 < x ≤ 0.2500 and y = 0.0200 as well as 0 < y ≤ 0.0667 and x = 0.1667 were successfully synthesized by high-temperature solid-state reaction method and combustion route. Obtained ceramic materials crystallize in scheelite-type structure with space group I41/a. Morphological features and grain sizes of powders under study were investigated by SEM technique. Spectroscopic studies within the UV-vis spectral range were carried out to estimate the direct band gap (Eg) and Urbach energy (EU) of obtained powders. EPR studies confirmed the existence of two types of magnetic objects, i.e., Mn2+ and Gd3+ ions, and significant antiferromagnetic (AFM) interactions among them

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

International audienceCitrate plays a central role in cancer cells’ metabolism and regulation. Derived from mitochondrial synthesis and/or carboxylation of α-ketoglutarate, it is cleaved by ATP-citrate lyase into acetyl-CoA and oxaloacetate. The rapid turnover of these molecules in proliferative cancer cells maintains a low-level of citrate, precluding its retro-inhibition on glycolytic enzymes. In cancer cells relying on glycolysis, this regulation helps sustain the Warburg effect. In those relying on an oxidative metabolism, fatty acid β-oxidation sustains a high production of citrate, which is still rapidly converted into acetyl-CoA and oxaloacetate, this latter molecule sustaining nucleotide synthesis and gluconeogenesis. Therefore, citrate levels are rarely high in cancer cells. Resistance of cancer cells to targeted therapies, such as tyrosine kinase inhibitors (TKIs), is frequently sustained by aerobic glycolysis and its key oncogenic drivers, such as Ras and its downstream effectors MAPK/ERK and PI3K/Akt. Remarkably, in preclinical cancer models, the administration of high doses of citrate showed various anti-cancer effects, such as the inhibition of glycolysis, the promotion of cytotoxic drugs sensibility and apoptosis, the neutralization of extracellular acidity, and the inhibition of tumors growth and of key signalling pathways (in particular, the IGF-1R/AKT pathway). Therefore, these preclinical results support the testing of the citrate strategy in clinical trials to counteract key oncogenic drivers sustaining cancer development and resistance to anti-cancer therapies

Immunity drives TET1 regulation in cancer through NF-κB

Ten-eleven translocation enzymes (TET1, TET2, and TET3), which induce DNA demethylation and gene regulation by converting 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), are often down-regulated in cancer. We uncover, in basal-like breast cancer (BLBC), genome-wide 5hmC changes related to TET1 regulation. We further demonstrate that TET1 repression is associated with high expression of immune markers and high infiltration by immune cells. We identify in BLBC tissues an anticorrelation between TET1 expression and the major immunoregulator family nuclear factor κB (NF-κB). In vitro and in mice, TET1 is down-regulated in breast cancer cells upon NF-κB activation through binding of p65 to its consensus sequence in the TET1 promoter. We lastly show that these findings extend to other cancer types, including melanoma, lung, and thyroid cancers. Together, our data suggest a novel mode of regulation for TET1 in cancer and highlight a new paradigm in which the immune system can influence cancer cell epigenetics.SCOPUS: ar.jinfo:eu-repo/semantics/publishe